Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

BUY
$119.57 - $139.07 $139,418 - $162,155
1,166 New
1,166 $149,000
Q2 2020

Aug 12, 2020

SELL
$48.02 - $79.04 $870,650 - $1.43 Million
-18,131 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$36.95 - $62.95 $149,610 - $254,884
-4,049 Reduced 18.26%
18,131 $942,000
Q4 2019

Feb 07, 2020

SELL
$47.06 - $56.64 $46,212 - $55,620
-982 Reduced 4.24%
22,180 $1.25 Million
Q1 2019

May 10, 2019

SELL
$29.84 - $43.92 $771,005 - $1.13 Million
-25,838 Reduced 52.73%
23,162 $940,000
Q4 2018

Feb 14, 2019

BUY
$29.95 - $46.34 $15,544 - $24,050
519 Added 1.07%
49,000 $1.53 Million
Q3 2018

Nov 09, 2018

SELL
$40.12 - $45.55 $8,264 - $9,383
-206 Reduced 0.42%
48,481 $2.21 Million
Q2 2018

Aug 10, 2018

SELL
$38.72 - $42.52 $142,838 - $156,856
-3,689 Reduced 7.04%
48,687 $2.04 Million
Q1 2018

May 14, 2018

BUY
$39.4 - $47.39 $871,134 - $1.05 Million
22,110 Added 73.05%
52,376 $2.15 Million
Q4 2017

Feb 13, 2018

SELL
$37.27 - $43.02 $37,829 - $43,665
-1,015 Reduced 3.24%
30,266 $1.24 Million
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $1.06 Million - $1.3 Million
31,281
31,281 $1.25 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.